Junjun Ling

504 total citations
37 papers, 368 citations indexed

About

Junjun Ling is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Junjun Ling has authored 37 papers receiving a total of 368 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 14 papers in Pulmonary and Respiratory Medicine and 10 papers in Cancer Research. Recurrent topics in Junjun Ling's work include Ferroptosis and cancer prognosis (12 papers), RNA modifications and cancer (8 papers) and Cancer-related molecular mechanisms research (6 papers). Junjun Ling is often cited by papers focused on Ferroptosis and cancer prognosis (12 papers), RNA modifications and cancer (8 papers) and Cancer-related molecular mechanisms research (6 papers). Junjun Ling collaborates with scholars based in China and Vietnam. Junjun Ling's co-authors include Wenlei Zhuo, Liang Zhang, Yi Huang, Xianlu Zhuo, Yi Zhu, Yunbo Luo, Zhengtang Chen, Bo Zhu, Zhen Yu and Liang Zhang and has published in prestigious journals such as PLoS ONE, Archives of Biochemistry and Biophysics and Journal of Histochemistry & Cytochemistry.

In The Last Decade

Junjun Ling

35 papers receiving 366 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Junjun Ling China 12 219 103 100 97 36 37 368
Pengcheng Luo China 12 152 0.7× 82 0.8× 70 0.7× 77 0.8× 49 1.4× 26 351
Meng Shang China 10 236 1.1× 72 0.7× 55 0.6× 84 0.9× 66 1.8× 22 469
Ettickan Boopathi United States 15 205 0.9× 68 0.7× 97 1.0× 60 0.6× 20 0.6× 27 463
Huixia Cao China 13 226 1.0× 59 0.6× 61 0.6× 134 1.4× 32 0.9× 40 471
Jun Ruan China 13 258 1.2× 61 0.6× 70 0.7× 85 0.9× 33 0.9× 18 388
Qianwei Xing China 14 281 1.3× 169 1.6× 61 0.6× 149 1.5× 22 0.6× 32 483
Shaoshui Chen China 9 169 0.8× 70 0.7× 97 1.0× 109 1.1× 20 0.6× 16 327
Zhaohua Gong China 12 200 0.9× 89 0.9× 84 0.8× 97 1.0× 19 0.5× 21 323
Alysia Kern Lovgren United States 6 171 0.8× 137 1.3× 84 0.8× 93 1.0× 14 0.4× 6 501

Countries citing papers authored by Junjun Ling

Since Specialization
Citations

This map shows the geographic impact of Junjun Ling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junjun Ling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junjun Ling more than expected).

Fields of papers citing papers by Junjun Ling

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junjun Ling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junjun Ling. The network helps show where Junjun Ling may publish in the future.

Co-authorship network of co-authors of Junjun Ling

This figure shows the co-authorship network connecting the top 25 collaborators of Junjun Ling. A scholar is included among the top collaborators of Junjun Ling based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junjun Ling. Junjun Ling is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ling, Junjun, et al.. (2024). Hydrogen-rich solution alleviates acute radiation pneumonitis by regulating oxidative stress and macrophages polarization. Journal of Radiation Research. 65(3). 291–302. 2 indexed citations
2.
3.
Wang, Yan, et al.. (2023). Identification of immune-related genes in the prognosis of head and neck cancer using a novel prognostic signature model. Oral Surgery Oral Medicine Oral Pathology and Oral Radiology. 136(4). 478–489. 2 indexed citations
4.
Ling, Junjun, et al.. (2022). Exploration of Potential Targets and Mechanisms of Fisetin in the Treatment of Non-Small-Cell Lung Carcinoma via Network Pharmacology and In Vitro Validation. Evidence-based Complementary and Alternative Medicine. 2022. 1–9. 12 indexed citations
6.
Ling, Junjun, et al.. (2022). Human papillomavirus 16 E6/E7 contributes to immune escape and progression of cervical cancer by regulating miR-142–5p/PD-L1 axis. Archives of Biochemistry and Biophysics. 731. 109449–109449. 21 indexed citations
7.
Ling, Junjun, et al.. (2022). Overexpression of KITLG predicts unfavorable clinical outcomes and promotes lymph node metastasis via the JAK/STAT pathway in nasopharyngeal carcinoma. Laboratory Investigation. 102(11). 1257–1267. 5 indexed citations
8.
Ling, Junjun, et al.. (2022). <i>SERPINE1</i> as an Independent Prognostic Marker and Therapeutic Target for Nicotine-Related Oral Carcinoma. Clinical and Experimental Otorhinolaryngology. 16(1). 75–86. 9 indexed citations
10.
Ling, Junjun, et al.. (2021). KIF11, a plus end-directed kinesin, as a key gene in benzo(a)pyrene-induced non-small cell lung cancer. Environmental Toxicology and Pharmacology. 89. 103775–103775. 10 indexed citations
11.
Ling, Junjun, et al.. (2020). Construction and analysis of miRNA-mRNA regulatory networks in the radioresistance of nasopharyngeal carcinoma. 3 Biotech. 10(12). 511–511. 6 indexed citations
12.
Xiang, Ying, et al.. (2019). Microarray-based data mining reveals key genes and potential therapeutic drugs for Cadmium-induced prostate cell malignant transformation. Environmental Toxicology and Pharmacology. 68. 141–147. 6 indexed citations
13.
14.
Zhang, Liang, Yi Huang, Junjun Ling, et al.. (2018). Is Integrin Subunit Alpha 2 Expression a Prognostic Factor for Liver Carcinoma? A Validation Experiment Based on Bioinformatics Analysis. Pathology & Oncology Research. 25(4). 1545–1552. 8 indexed citations
15.
Ling, Junjun, et al.. (2017). Association of KIBRA polymorphism with risk of Alzheimer’s disease: Evidence based on 20 case-control studies. Neuroscience Letters. 662. 77–83. 7 indexed citations
16.
Zhuo, Xianlu, et al.. (2012). Lack of association of the cyclin D1 G870A variation with oral carcinoma risk: Evidence from 2,404 subjects. Experimental and Therapeutic Medicine. 4(4). 748–754. 4 indexed citations
17.
Zhuo, Wenlei, Liang Zhang, Bo Zhu, Junjun Ling, & Zhengtang Chen. (2012). Association of MDM2 SNP309 Variation with Lung Cancer Risk: Evidence from 7196 Cases and 8456 Controls. PLoS ONE. 7(7). e41546–e41546. 22 indexed citations
18.
Zhuo, Wenlei, et al.. (2012). CYP2E1 RsaI/PstI Polymorphism and Gastric Cancer Susceptibility: Meta-Analyses Based on 24 Case-Control Studies. PLoS ONE. 7(11). e48265–e48265. 15 indexed citations
19.
Zhuo, Wenlei, Liang Zhang, Junjun Ling, Yi Zhu, & Zhengtang Chen. (2012). MTHFR C677T and A1298C polymorphisms and cervical carcinoma susceptibility: meta-analyses based on 4421 individuals. Molecular Biology Reports. 39(9). 8723–8732. 8 indexed citations
20.
Zhuo, Xianlu, et al.. (2012). NAT2 polymorphisms with oral carcinoma susceptibility: a meta-analysis. Molecular Biology Reports. 39(9). 8813–8819. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026